Bixiye
QP85-22 MHCP Pharmacy Benefit Update: New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Radicava® (edaravone)
Taariikhda uu dhaqangalayo barnaamijka: Okt 26, 2022
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1961 - 1970 ee natiijooyinka 3289
Bixiye
QP83-22 MHCP Pharmacy Benefit Exclusion for Somatuline® Depot and Sandostatin® LAR Depot
Taariikhda uu dhaqangalayo barnaamijka: Okt 26, 2022
Bixiye
QP82-22 MHCP Pharmacy Benefit Update New drug-related PA with QL Criteria Vijoice® (alpelisib)
Taariikhda uu dhaqangalayo barnaamijka: Okt 12, 2022
Bixiye
QP80-22 Commercial Pharmacy Benefit Update: New and Revised Drug-Related PA Requirement Notification, Effective December 1, 2022
Taariikhda uu dhaqangalayo barnaamijka: Okt 12, 2022
Bixiye
QP81-22 MHCP Pharmacy Benefit Exclusion for Zynteglo®
Taariikhda uu dhaqangalayo barnaamijka: Okt 12, 2022
Bixiye
QP79-22 New Commercial Pharmacy Benefit Exclusion for Zynteglo®
Taariikhda uu dhaqangalayo barnaamijka: Okt 12, 2022
Bixiye
P65-22 Mental Health and Substance Use Disorder Provider Survey – New Due Date
Taariikhda uu dhaqangalayo barnaamijka: Okt 03, 2022
Bixiye
2022 October Bulletins
Taariikhda uu dhaqangalayo barnaamijka: Okt 03, 2022